Objectives: Tolerance refers to the phenomenon that bacteria do not significantly die when exposed to bactericidal antibiotics. Enterococci are known for their high tolerance to these drugs, but the molecular reasons why they resist killing are not understood. In a previous study we showed that the superoxide dismutase (SOD) is implicated in this tolerance. This conclusion was based on the results obtained with one particular strain of Enterococcus faecalis and therefore the objective of the present communication was to analyse whether dependence of tolerance on active SOD is a general phenomenon for enterococci and another Gram-positive pathogen, Staphylococcus aureus.
Introduction
Resistance to antibiotics is continuously increasing. Therefore there is a constant demand for new compounds or innovative treatment strategies. However, the approval of new antibiotic compounds has decreased considerably during recent decades. 1 As a consequence, treatment strategies that try to increase the action of existing antimicrobials would be of great benefit. Of special interest in this respect are bactericidal drugs that efficiently kill pathogens. These drugs are expected to cure disease more rapidly and restrict the emergence of resistance better than bacteriostatic antibiotics. Despite the importance of bactericidal antibiotics for successful treatment, surprisingly little is known about the mechanisms of how these drugs actually kill bacteria. It is generally believed that killing is due to the primary action of antibiotics, i.e. through the disruption of cell wall synthesis by cell wall active compounds like penicillins or glycopeptides, or through the inhibition of DNA replication and induction of DNA double-strand breaks by gyrase inhibitors such as fluoroquinolones. In the case of cell wall active compounds it has been shown that peptidoglycan hydrolases contribute to killing in a cell density-dependent manner. 2, 3 Recently another mechanism for antibiotic-induced cell death has been proposed. 4, 5 Based on system-level analysis mainly conducted with Escherichia coli, this cell death pathway model proposes that bactericidal antibiotics regardless of their primary targets also induce cell death by generating reactive oxygen species (ROS). 5, 6 ROS can block growth by inactivating key metabolic enzymes, but the actual lethal effects are thought to be mainly due to ROS-induced DNA damage. 4, 6, 7 Enterococci are widespread in nature and are found as intestinal commensals of humans and many other animals. Two species in particular, Enterococcus faecalis and Enterococcus faecium, have emerged over the past few decades as the second or third most common cause of nosocomial infections worldwide. 8 These organisms are causing increasing concerns in public health since they can exhibit high levels of resistance to common anti-Gram-positive antimicrobials. 8 In addition, E. faecalis exhibits tolerance to the bactericidal effects of cell wall active agents as well as gyrase inhibitors. 9 -11 By definition, antibiotics are considered as bactericidal if viable counts are reduced by at least 99.9% after 24 h of exposure. 12 We showed recently that 80%, 7% and 7% of E. faecalis strain JH2-2 survived treatment for 24 h with 20-fold the MIC of vancomycin, penicillin and norfloxacin, respectively. 9 By testing single or multiple deficient mutants affected in oxidative stress defence activities or DNA repair, we demonstrated that the only mutant significantly killed by bactericidal but not bacteriostatic antibiotics was the one with an inactivated sodA gene. 9 Of note, E. faecalis harbours only one gene encoding a manganese-cofactored superoxide dismutase (SOD). 13 The most spectacular decrease in antibiotic tolerance was observed for treatments with vancomycin and penicillin with sensitization factors of the DsodA mutant of nearly 10 4 -fold compared with the wild-type. 9 These results demonstrated that the hitherto unexplained tolerance of E. faecalis to bactericidal antibiotics seems to be linked to SOD activity and hence bactericidal antibiotics kill this species by inducing a superoxide burst. However, in contrast to our data, two studies reported that E. coli SodA/SodB-deficient mutants were significantly more resistant to killing by ampicillin, norfloxacin or gentamicin. 14, 15 Another study reported that a single DsodA mutant of E. coli had no discernible phenotype when exposed to norfloxacin, but under these conditions the DsodB single mutant exhibited a decreased survival at longer treatment times compared with the wild-type. 6 Furthermore, survival of a DsodA mutant of Listeria monocytogenes was comparable to that of the wild-type when exposed to several bactericidal antibiotics. 14 So we could not exclude that the observed effect of SOD deficiency on tolerance was strain dependent and specific to the E. faecalis JH2-2 strain. We therefore decided to analyse the relationship between SOD deficiency and sensitivity to bactericidal cell wall active drugs in more detail.
In this communication we show that: (i) loss of tolerance to vancomycin and penicillin due to SOD deficiency is a general trait of susceptible strains of E. faecalis and E. faecium; (ii) this phenomenon is not observed in a non-tolerant E. faecium strain; (iii) tolerance is directly correlated with sodA expression level; and (iv) the Mn-SOD enzymes SodA and SodM of the major human pathogen Staphylococcus aureus also protect the cells against killing by vancomycin, albeit to a lesser extent than enterococci. Finally, since loss of tolerance has been shown hitherto only in laboratory media, we tested if killing of SOD-deficient strains also takes place under infection-mimicking conditions.
Materials and methods

Bacterial strains, plasmids, and growth conditions
Strains and plasmids used in this study are described in Table S1 (available as Supplementary data at JAC Online) and the oligonucleotides in Table S2 (available as Supplementary data at JAC Online). E. faecalis and E. faecium were grown in M17 medium 16 supplemented with 0.5% (w/v) glucose (GM17) and S. aureus strains were grown in tryptic soy broth (TSB) at 378C under aerobic conditions (100 mL Erlenmeyer flasks filled with 10 mL of growth medium, stirred at 60 or 120 rpm). When necessary, the media were supplemented with 150 mg/L erythromycin or 15 mg/L chloramphenicol for E. faecalis and E. faecium strains. For S. aureus cultures, we used the following antibiotic concentrations when needed: 5 mg/L of erythromycin, 3 mg/L of tetracycline and 100 mg/L of kanamycin. The growth kinetics of the cultures were followed both by measurement of optical density at 600 nm (OD 600 ) with a biophotometer (Eppendorf, Hamburg, Germany) and by viable cfu counts on agar plates. E. faecium strains used for conjugation with E. faecalis were obtained from the national enterococcal strain collection of the University Hospital in Caen and are clinical isolates with natural conjugative plasmids harbouring the vanB operon. These strains are not listed in Table S1 (available as Supplementary data at JAC Online) because little information is available for them. The reference numbers of these strains are 07/005, 08/048 and 08/140. E. coli strains were cultivated at 378C in Luria-Bertani (LB) 17 broth with vigorous shaking (160 rpm). When appropriate, 100 mg/L ampicillin, 150 mg/L erythromycin or 10 mg/L chloramphenicol was added to the medium. Bacterial stocks were stored at 2808C in GM17, TSB or LB broth supplemented with glycerol 15% (v/v).
Susceptibility testing and time -kill curves
The MICs were determined by the Etestw method. Time-kill curves were determined with exponentially growing cultures by adding vancomycin or penicillin to a final concentration of 20 mg/L for E. faecalis and E. faecium strains and 5 mg/L for S. aureus strains at an OD 600 of 0.5 (corresponding to 4×10 8 cfu/mL). Growth was followed by measuring the OD 600 at regular intervals and cfu counts were determined after 24 h of incubation by plating 10-fold serial dilutions of the cultures on GM17 agar plates. The number of survivors giving rise to colonies was determined after 48 h of incubation of the plates at 378C. Antibiotic killing was assessed as the percentage of surviving colonies relative to the viable count at the time of drug addition. The sensitization factor is defined as the ratio of survival of a parent strain to that of a mutant strain.
General molecular methods
Molecular cloning and other standard techniques were performed as described. 17 Antibiotics, chemicals and enzymes were reagent-grade, commercially available products. E. coli, E. faecalis and E. faecium were transformed by electroporation 18 using the Gene Pulser apparatus (Bio-Rad Laboratories, Marnes la Coquette, France). Plasmids and PCR products were purified using Qiagen kits (Qiagen, Courtaboeuf, France).
Construction of the E. faecalis OG1RFDsodA mutant
The E. faecalis OG1RFDsodA mutant was constructed by allelic exchange using a method based on the conditional replication of the pLT06 vector. 19 For this purpose we used a previous E. faecalis JH2-2 DsodA mutant. 13 The JH2-2 DsodA mutant was used to prepare the DNA template for PCR amplification using Triple Master Polymerase Mix (Eppendorf, Hamburg, Germany) of a 2.7 kb DNA fragment harbouring a sodA deletion using the primers sodmadecoI and sodmad2 (Table S2 , available as Supplementary data at JAC Online) containing EcoRI and NcoI restriction sites, respectively. The sodA mutation consists of the introduction of two stop codons separated by a BamHI site and a central deletion of 8 bp in the coding sequence of the sodA gene leading to a truncated protein of 112 amino acids. 13 The 2.7 kb PCR product was digested by EcoRI and NcoI and cloned into pLT06 vector already equally treated with the same two enzymes and finally transformed into electrocompetent cells of E. coli XL-1 blue. The resulting recombinant plasmid containing the mutated sodA gene was used to transform E. faecalis OG1RF. After electroporation the plasmid was maintained at the permissive temperature of 308C by plating cells on GM17 agar medium containing chloramphenicol and X-Gal. The transformed colonies were verified by PCR for the presence of recombinant plasmid and then used to trigger the first crossing-over by applying the non-replicative condition of the vector (448C/GM17 chloramphenicol). Single-crossover transformants (chloramphenicol-resistant) were used for temperature shifts (308C/GM17 without antibiotic) in order to release the plasmid. Following this step, chloramphenicol-susceptible clones were screened for the presence of the mutated sodA allele by restriction analysis (BamHI digestion) of the PCR product, DNA sequencing and a zymogram for the absence of SOD activity.
Construction of DsodA mutants of E. faecium Com12 and E. faecium 1,141,733
DsodA mutants of E. faecium Com12 and E. faecium 1,141,733 were constructed by double crossing-over mutagenesis using the pLT06 vector as described below for the E. faecalis OG1RFDsodA mutant. From the genomic DNA of E. faecium Com12 we amplified by PCR with Com1NCO1/ StopRev primer pair (Table S2 , available as Supplementary data at JAC Online) a 986 bp DNA fragment including the 228 bp of the 5 ′ part of the sodA gene and its upstream region and a second DNA fragment of 1341 bp using the Stopfor/Com4Rev primer pair (Table S2 , available as Supplementary data at JAC Online) corresponding to the remaining 405 bp of the sodA gene and its downstream region ( Figure S1 , available as Supplementary data at JAC Online). The Stopfor and StopRev primers share a complemented sequence of 24 bp, where four stop codons were inserted (Figure S1, available as Supplementary data at JAC Online). To generate the entire DNA fragment harbouring the mutated sodA gene, a second PCR was performed using the primer pair Com1NCO1/Com4Rev and the mix of the two previous amplified fragments as template DNA. The resulting DNA fragment of 2.3 kb was excised from the agarose gel electrophoresis and purified. After digestion with appropriate restriction enzymes, this fragment was cloned into pLT06 plasmid to generate pLT06DsodACom12. This recombinant plasmid was used to transform both E. faecium Com12 and E. faecium 1,141,733. Comscreenfor primer (Table S2 , available as Supplementary data at JAC Online) was designed on the basis of the modified sequence of the sodA gene ( Figure S1 , available as Supplementary data at JAC Online) to allow the screening by PCR of the chloramphenicol-susceptible clones obtained after the second crossing-over event. When Comscreenfor was used in combination with the Com1coRev primer (located outside of the construct; Figure S1 , available as Supplementary data at JAC Online), only the DsodA mutant clones gave rise to a 1.34 kb DNA product. The absence of SOD enzymatic activity was also verified by zymogram.
Construction of the E. faecium HM1070DsodA mutant
The HM1070DsodA mutant was derived from E. faecium HM1070 by allelic exchange with a truncated copy of sodA and using conditional replication of the pG(+)Host9 vector as described. 20 Fragments upstream (680 bp) and downstream (686 bp) of sodA were amplified by PCR using HM1070 chromosome as template and primer pairs HMsod1NcoI/HMsod2BamH1 and HMsod3BamHI/HMsod4SalI (Table S2 , available as Supplementary data at JAC Online). The forward primer binding to the 3 ′ -end of sodA (HMsod3BamHI) and the reverse primer to the 5 ′ -end (HMsod2BamH1) were modified to carry the same restriction site (Table S2 , available as Supplementary data at JAC Online). Following restriction, ligation and reamplification using HMsod1NcoI/HMsod4SalI, the resulting fragment carrying the truncated sodA copy was cloned in the temperature-sensitive shuttle vector pG(+)Host9 to create the plasmid pG(+)host9DsodAHM1070 (Table S1 , available as Supplementary data at JAC Online). The hybrid plasmid was introduced into HM1070 by electrotransformation and homologous recombination followed by excision of the wild-type copy, as described previously. 20 Deletion of 63% of the sodA gene was confirmed by PCR and DNA sequencing using the HMsodcont primer (Table S2 , available as Supplementary data at JAC Online).
Complementation of the E. faecalis JH2-2 and OG1RF DsodA mutants For the complementation assays, a DNA fragment containing the entire sodA gene of E. faecalis JH2-2 was obtained by PCR using primers SODCOMP-BAM and SODCOMPPST (Table S2 , available as Supplementary data at JAC Online) harbouring BamHI and PstI sites, respectively. The PCR product was cloned into the pMSP3535 plasmid 21 downstream of the nisin-inducible promoter (Pnis). Recombinant plasmid was first transformed in E. coli Top10 cells, amplified and finally used to transform competent cells of the E. faecalis DsodAJH2-2 and DsodAOG1RF mutants. After electroporation, 300 mL of cell suspension was plated onto GM17 agar containing erythromycin. The plates were incubated for 48 h at 378C. The colonies obtained were analysed for the presence of the plasmid containing an intact sodA gene by DNA sequencing of the PCR product using primers p3535For1 and p3535Rev2 (Table S2 , available as Supplementary data at JAC Online) and SOD activity was detected by zymogram.
Preparation of cell extracts, PAGE and SOD activity detection
Cultures of E. faecalis, E. faecium, S. aureus and their derivative sod mutants were harvested by centrifugation, the pellets were washed once in 50 mM Tris, 7 mM DTT, 1.06 mM EDTA (pH 7.0), and finally resuspended in 50mM Tris (tris hydroxymethyl aminomethane), 2 mM EDTA, 100 mM NaCl and 5 mM DTT (pH 7.0). Glass beads (0.1-0.25 mm diameter) were added and the cells were disrupted by vortexing for 5 min. The samples were chilled on ice, and the extraction procedure was repeated. After centrifugation for 10 min at 6000 g, cell debris and unbroken cells were removed. The supernatants were transferred to new tubes. The protein concentration was determined by the method of Bradford. 22 Non-denaturing PAGE was carried out according to the protocol of Laemmli, 23 except that SDS and mercaptoethanol were omitted. Equal amounts of proteins (30 mg) were loaded in each lane, and the gel was used to detect SOD activity according to the protocol of Beauchamp and Fridovich. 24 
Statistics
Differences among strains in killing by bactericidal antibiotics were calculated using the Student's t-test. P values ,0.05 were considered to be significant.
Results
Antibiotic tolerance disappears in DsodA mutants of susceptible but not resistant E. faecalis strains
The exact molecular mechanisms explaining why E. faecalis is more tolerant to bactericidal antibiotics than other pathogenic cocci are not yet understood. In a previous study we showed that inactivation of the sodA gene encoding SOD led to the collapse of tolerance to the cell wall active antibiotics vancomycin, penicillin and, to a lesser extent, to the gyrase inhibitor norfloxacin in E. faecalis strain JH2-2. 9 Due to the well-known enzymatic activity of SOD, we proposed that bactericidal drugs induce a superoxide burst in E. faecalis and that superoxide anion accumulates to toxic levels in the DsodA mutant, explaining why survival dropped by several orders of magnitude in the SOD-deficient compared Analysis of the tolerance of pathogenic enterococci 2085 JAC with the parental strain. The model has been experimentally supported since a catalase-peroxidase mutant accumulated H 2 O 2 when treated with a bactericidal but not with a bacteriostatic antibiotic. 9 E. faecalis is characterized by great genetic and phenotypic diversity. 25 -27 Therefore we wondered if the loss of tolerance of a DsodA mutant is a strain-independent phenomenon and decided to construct DsodA deletion mutants in other E. faecalis strains. First we tried to delete the sodA gene in the vancomycin-resistant clinical isolate V583, which carries a chromosomal vanB operon. 28 The idea was to analyse if induction of the oxidative burst we postulated from our previous results is a consequence of disruption of cell wall synthesis provoked by vancomycin or if it is independent of its primary action. In E. coli, oxidative stress has been shown to be secondary to the primary modes of action of bactericidal antibiotics since ROS could be detected upon treatment of susceptible but not resistant bacteria. 6, 29 However, all attempts to construct a DsodA mutant in strain V583 were unsuccessful. We concluded that for unknown reasons inactivation of the sodA gene in this vancomycin-resistant clinical isolate does not seem possible.
To answer the question whether primary action of the bactericidal antibiotics is a prerequisite for induction of the oxidative burst or if it is independent of it, we then transferred by conjugation VanB resistance into the DsodA mutant of E. faecalis strain JH2-2 using E. faecium strains as donors harbouring the resistance operons on plasmids. The transconjugants obtained not only survived exposure to 20 mg/L (corresponding to 20-fold MIC of susceptible strains) of vancomycin, but were able to grow in the presence of this concentration of the antibiotic (data not shown). This demonstrates that, like in E. coli, the oxidative stress is triggered by the primary mode of action of vancomycin.
Using the same tools as above for strain V583, we then tried to construct a DsodA mutant in another vancomycin-and penicillinsensitive E. faecalis strain. We used the laboratory strain OG1RF and obtained the mutant without any difficulty. Of note, the MIC values of the mutant were unchanged in comparison to the parent strain. The sensitivity of the mutant to exposure to 20 mg/ L of penicillin and vancomycin was then tested. Against both antibiotics the DsodA mutant was significantly more susceptible than the parent strain, with sensitization factors of .10 3 and .10 4 , respectively (Figure 1 ), confirming the result obtained with strain JH2-2. Furthermore, complementation in trans restored tolerance to vancomycin and penicillin (Figure 1) . These data indicate that efficient killing of SOD-deficient mutants by cell wall active bactericidal antibiotics is a strain-independent phenomenon in E. faecalis.
Degree of tolerance is correlated with SOD activity in E. faecalis
The above-mentioned in trans complementation has been achieved by cloning the wild-type sodA allele of E. faecalis strain JH2-2 into plasmid pMSP3535 21 under the control of the nisin-inducible promoter of this vector. This construction opened the possibility of varying the level of expression of Mn-SOD by using different nisin concentrations for induction. As shown in Figure 2 , SOD activity could be detected even without nisin induction, demonstrating that the PnisA promoter on this vector is somewhat leaky. However, the addition of nisin to the culture induced sodA expression since a stronger activity band was present on the zymogram under these conditions ( Figure 2 ). We then tested DsodA Van20
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survival against 20 mg/L of vancomycin of the DsodA mutant of strain JH2-2 harbouring either the empty pMSP3535 vector or the recombinant plasmid pMSP3535::sodA in the presence or absence of nisin. The DsodA mutant with the empty vector was highly susceptible to killing by vancomycin independent of the presence or absence of nisin ( Figure 2) . The SOD-deficient strain harbouring the recombinant plasmid in the absence of nisin significantly restored tolerance to the glycopeptide. However, tolerance of this strain was virtually fully restored to the wild-type level by inducing sodA expression by the addition of nisin. This demonstrates that the degree of tolerance to vancomycin is directly correlated with SOD activity.
SodA deficiency sensitizes vancomycin-tolerant but not non-tolerant E. faecium strains E. faecium is the second enterococcal species of clinical importance. 8 Currently 40% of enterococcal nosocomial infections in Europe and US hospitals are caused by this bacterium. 30, 31 So we wondered whether deletion of the sodA gene would have an effect on tolerance to bactericidal antibiotics in this species as well. Before starting the construction of DsodA mutants, we tested the tolerance of different E. faecium strains to vancomycin (Figure 3 ). We chose five E. faecium strains from the Broad Institute and strain HM1070. 32 Of note, all these strains have MICs of 1 mg/L as determined by Etest. With the exception of the last strain, all isolates were highly tolerant against killing by 20 mg/L of vancomycin with survival rates of about 50% after 24 h of exposure (Figure 3) . In contrast, .99.9% of cells of E. faecium strain HM1070 were killed by this treatment. Based on these results, we decided to construct DsodA-deficient mutants in two vancomycin-tolerant E. faecium strains (strains Com12 and 1,141,733) and in the non-tolerant strain HM1070. As for E. faecalis, the vancomycin MIC values of the mutant strains were unchanged compared with the respective wild-type strains. The DsodA mutants of both tolerant strains were significantly killed by exposure to 20 mg/L of vancomycin (Figure 4 ), although SodA deficiency seems to have a slightly greater sensitization effect in strain Com12 than in strain 1,141,733. The former strain was also tested for survival against 20 mg/L of penicillin. The wild-type strain proved tolerant to this treatment, with a survival rate of 42% of the population after 24 h of incubation (Figure 4) . In contrast, the isogenic SOD-deficient strain lost its tolerance to this b-lactam antibiotic since .99.99% of the population was killed by this treatment.
The results of the E. faecium strain HM1070 and its isogenic DsodA mutant are different from those of the two other strains. As mentioned above, the HM1070 wild-type strain is, in contrast to the other E. faecium isolates tested, not tolerant to treatment with 20 mg/L of vancomycin. Interestingly, its survival rate is comparable to that of the DsodA mutant of strain 1,141,733 ( Figure 4 ). Introduction of a mutation in the sodA gene in strain HM1070 showed no additional effect on survival against 10 mg/L of vancomycin in comparison to the control strain (Figure 4) . A similar result has been obtained using 5 mg/L or 20 mg/L of this glycopeptide (data not shown). Furthermore, both strains were also exposed to 20 mg/L of penicillin, corresponding to 20-fold the MIC of this strain. Survival was extremely low under these conditions, but no difference between the mutant and the wild-type strain was observed (data not shown). From these results we speculated that strain HM1070 might have a natural deficiency of SOD activity.
However, this was not the case, since the SOD activity was revealed in this strain but not in the DsodA mutant by zymogram assay (data not shown). Furthermore, an increase of SOD activity by introduction of plasmid pMSP3535::sodA into the HM1070 strain did not significantly increase tolerance, demonstrating that the SodA level is also not the limiting factor (data not shown). However, we noticed an important decrease of the OD 600 from 0.5 to 0.03 for the cultures of strain HM1070 after 24 h of treatment, whereas a decrease in OD 600 is not observed for the tolerant E. faecium strains under these conditions. This decrease in OD 600 for strain HM1070 was not observed in cultures incubated for 24 h without vancomycin. This suggests that in the case of the non-tolerant E. faecium strain HM1070, cell death is due to cell lysis triggered by vancomycin.
Tolerance to vancomycin is correlated with SOD activity in S. aureus
In contrast to E. faecalis, which has only one sodA gene, S. aureus harbours two sod genes, both of them encoding manganese-type SOD enzymes (SodA and SodM). 33 Therefore this was an interesting context to test whether one or both Mn-SODs are also implicated in tolerance to bactericidal antibiotics in this important human pathogen. We used vancomycin as a model for these experiments and tested three S. aureus strains: the wild-type strain SH1000 and isogenic DsarA and DsarA/DsodA/DsodM mutants.
SarA has been shown to be a pleiotropic transcriptional regulator of virulence factors 34 and, most important for the context of the present study, also regulates expression of sodA and sodM genes. 35 This last study showed that both genes, but in particular sodM, are overexpressed in a sarA mutant, leading to an increase in SOD activity in this strain. So we were interested to test if this is correlated with an increase in tolerance to vancomycin and if inactivation of the two sod genes also affects tolerance in S. aureus.
We first tested resistance of strain SH1000 and isogenic mutants to vancomycin by Etest. This showed that the MICs of all strains were 2 mg/L. Based on these results, we tested tolerance by exposing the wild-type strain for 24 h to 20-fold its MIC for vancomycin. However, survival rates were extremely low under these conditions, indicating that S. aureus seems to be less tolerant Analysis of the tolerance of pathogenic enterococci 2087 JAC than enterococci towards this glycopeptide. By testing different concentrations and exposure times, we finally conducted the following experiments with 5 mg/L vancomycin, which is only two to three times higher than the MIC of the different strains. Using these conditions, survival of the wild-type strain was 30% after 6 h of treatment ( Figure 5 ). The survival of mutants affected in either one of the two sod genes was comparable to that of the parent strain (data not shown), whereas the sarA single mutant was more tolerant than the wild-type, which may be explained by the higher SOD activity in this mutant. However, a P value of 0.17 indicates that the difference between the two strains seems not statistically significant ( Figure 5 ). Interestingly, the DsarA/ DsodA/DsodM mutant was significantly more susceptible in comparison to the wild-type (P,0.001) and the sarA mutant strain (P,0.05) ( Figure 5) , with sensitization factors of 20-fold and nearly 10 2 -fold, respectively. We concluded that SOD activity contributes to protect cells against killing by the bactericidal antibiotic of this pathogen as well, although to a much lesser extent than enterococci.
Loss of tolerance is also observed under infection-mimicking conditions in enterococci
The experiments presented so far were all conducted in the laboratory medium GM17. Of note, in Brain Heart Infusion medium the DsodA mutant of strain JH2-2 was also more susceptible to vancomycin than the wild-type (data not shown). We concluded that loss of tolerance in SOD-deficient mutants is independent of the growth medium. Finally, we examined whether loss of tolerance of SODdeficient enterococci could also be observed under infectionmimicking conditions. We used horse serum for these experiments and exposed wild-type bacteria and isogenic DsodA mutants to 20 mg/L of vancomycin. The DsodA mutants of E. faecalis (strains JH2-2 and OG1RF) and the tolerant E. faecium strains were significantly more susceptible to vancomycin than their isogenic wildtype control (Figure 6 ).
Discussion
The combined results of this study corroborate that tolerance to cell wall bactericidal antibiotics is intimately linked to SOD activity in enterococci and to a lesser extent in S. aureus. However, enterococci seem to be more suitable than S. aureus for tolerance studies since these bacteria are more tolerant than S. aureus to cell wall active drugs. It seems that the more a bacterium is tolerant, the greater is the negative effect of SOD deficiency on survival. This hypothesis would also provide an explanation for the absence of an effect of SOD deficiency on survival with norfloxacin, gentamicin Ladjouzi et al.
or kanamycin in L. monocytogenes. 14 This pathogen is not tolerant to these antibiotics since it is rapidly killed by these drugs. 14 Thus, according to the hypothesis above, SOD activity should not have an additional role in survival against these agents. Very contrasting results have been published for E. coli. One study found a slightly higher sensitivity to norfloxacin of a DsodB mutant in comparison to the wild-type strain, 6 but two other studies reported that individual SOD-deficient strains demonstrated no difference, whereas the corresponding double DsodA/ DsodB mutant was significantly (10-to 100-fold) more tolerant to norfloxacin, ampicillin and kanamycin than the parental strain. 14, 15 The Gram-negative enterobacteria are very different from enterococci. E. coli is not tolerant to bactericidal antibiotics and has a functional tricarboxylic acid (TCA) cycle and a respiration chain. TCA and the respiration chain are key components for the cell death pathway model that proposes a cascade of radical reactions triggered by the stimulation of central metabolism and respiration, leading to the killing of cells by bactericidal antibiotics. 5, 36 However, the E. coli cell death pathway model, which has been called into question in two very recent publications, 37,38 cannot be extrapolated to enterococci since key elements like the TCA cycle and, in the case of E. faecium, the respiration chain are absent. 39 Overall, this excludes that perturbation of the respiratory chain is responsible for antibiotic-mediated generation of O 2 2 . in enterococci. Because the mechanisms of induction of the superoxide burst are different in E. coli and enterococci, we suspect that these fundamental differences may account for the different behaviours of SOD-deficient mutants when exposed to bactericidal antibiotics in these bacteria. It would now be interesting to elucidate how these drugs actually provoke the generation of superoxide in enterococci and to define the cascade of events leading finally to cell death in SOD-deficient mutants.
An interesting result of this study was the identification of an E. faecium strain that was not tolerant to vancomycin. Loss of tolerance of the HM1070 isolate was independent of SOD activity since an isogenic DsodA mutant was not more susceptible than the wild-type and overexpression of SodA in the wild-type strain did not significantly increase tolerance. Recently it has been proposed that killing by the b-lactam antibiotic amoxicillin is due to two mechanisms in E. faecalis strain JH2-2. One seems to be based on the induction of an internal oxidative stress and the other is due to the action of autolysins. 2 We noticed for the nontolerant E. faecium strain an important decrease in the OD 600 after 24 h of treatment with vancomycin. Such a phenomenon was not observed with the tolerant E. faecium as well as for the E. faecalis strains used in this study. This suggests that strain HM1070, which seems to be atypical among enterococci, is predominantly killed by vancomycin via a lysis-dependent but SOD-independent cell death mechanism. However, cell lysis is not observed in cultures grown for 24 h in the absence of antibiotic, suggesting that lysis is due to the combined action of vancomycin and autolysins. A similar result has been described for the lysis of Streptococcus pneumoniae when exposed to penicillin. 3 It will now be important to deduce the underlying molecular mechanisms for the absence of lysis of tolerant E. faecium strains as well as the increased lysis of non-tolerant E. faecium strains in more detail. One hypothesis could be a differential expression of peptidoglycan hydrolases, as proposed for pneumococci, 3 in tolerant and non-tolerant enterococci. Another possibility is induction of a prophage by the antibiotic treatment. Such a possibility cannot be excluded at the moment, although our preliminary results do not support this concept.
In conclusion, the results presented in this study indicate that it is possible to abolish the tolerance of enterococci and S. aureus by deficiency in SOD activity. Therefore a drug targeting the Mn-SODs of these organisms should improve the chemotherapeutic efficacy of treatment of enterococcal infections with cell wall active antibiotics. 
